Prognosis of Small Cell Lung Cancer with Idiopathic Pulmonary Fibrosis: Assessment according to GAP Stage.
Myung Jin SongSung Yoon LimJong Sun ParkHo Il YoonJae-Ho LeeSong Yee KimJi Ye JungYoung Ae KangMoo Suk ParkYoung Sam KimJoon ChangSang Hoon LeeChoon-Taek LeePublished in: Journal of oncology (2019)
Inferior survival outcome and higher incidence of treatment-related pulmonary toxicities were noted in the advanced GAP stage group. Furthermore, advanced GAP stage was the only predictor of treatment-related acute exacerbation of IPF. Physicians should thus consider GAP stage, which reflects the severity of IPF, during treatment of SCLC-IPF.
Keyphrases
- idiopathic pulmonary fibrosis
- small cell lung cancer
- interstitial lung disease
- primary care
- chronic obstructive pulmonary disease
- risk factors
- pulmonary hypertension
- respiratory failure
- liver failure
- drug induced
- intensive care unit
- combination therapy
- hepatitis b virus
- replacement therapy
- systemic sclerosis
- mechanical ventilation